Serum survivin and vascular endothelial growth factor in extranodal NK/T-cell lymphoma, nasal type: implications for a potential new prognostic indicator

Haematologica. 2015 Mar;100(3):e106-9. doi: 10.3324/haematol.2014.116087. Epub 2014 Dec 5.

Authors

Seok Jin Kim¹, Mineui Hong², In-Gu Do², Seung Ho Lee³, Kyung Ju Ryu⁴, Hae Yong Yoo⁵, Jung Yong Hong⁶, Young Hyeh Ko², Won Seog Kim⁷

Affiliations

¹ Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea.
² Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea.
³ Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Korea.
⁴ Samsung Biomedical Research Institute, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
⁵ Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Korea Samsung Biomedical Research Institute, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea.
⁶ Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
⁷ Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea [email protected].

No abstract available

Keywords: extranodal NK/T-cell lymphoma; prognosis; serum; survivin; vascular endothelial growth factor.

Publication types

Clinical Trial
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Aged
Antineoplastic Agents / therapeutic use
DNA, Viral / blood
DNA, Viral / genetics
Epstein-Barr Virus Infections / blood
Epstein-Barr Virus Infections / diagnosis*
Epstein-Barr Virus Infections / drug therapy
Epstein-Barr Virus Infections / genetics
Female
Gene Expression
Herpesvirus 4, Human / genetics
Humans
Inhibitor of Apoptosis Proteins / blood
Inhibitor of Apoptosis Proteins / genetics*
Interleukin-6 / blood
Interleukin-6 / genetics
Lymphoma, Extranodal NK-T-Cell / blood
Lymphoma, Extranodal NK-T-Cell / diagnosis*
Lymphoma, Extranodal NK-T-Cell / drug therapy
Lymphoma, Extranodal NK-T-Cell / genetics
Male
Middle Aged
Nose Neoplasms / blood
Nose Neoplasms / diagnosis*
Nose Neoplasms / drug therapy
Nose Neoplasms / genetics
Platelet-Derived Growth Factor / genetics
Platelet-Derived Growth Factor / metabolism
Prognosis
Prospective Studies
Signal Transduction
Survival Analysis
Survivin
Vascular Endothelial Growth Factor A / blood
Vascular Endothelial Growth Factor A / genetics*

Substances

Antineoplastic Agents
BIRC5 protein, human
DNA, Viral
IL6 protein, human
Inhibitor of Apoptosis Proteins
Interleukin-6
Platelet-Derived Growth Factor
Survivin
VEGFA protein, human
Vascular Endothelial Growth Factor A

Associated data

ClinicalTrials.gov/NCT00822731
ClinicalTrials.gov/NCT01877109